HCmed provides fully customizable end-to-end services for inhaled drug-device combination products. From early-stage feasibility and custom formulation compatibility testing to clinical manufacturing, we tailor solutions to meet specific partner needs.
Archives
Full-spectrum development services, optimizing drug formulations for small and large molecules (biologics) across multiple delivery routes, including pulmonary, nasal, injectable and dermal.
Lonza Pharma & Biotech provides integrated DPI (dry powder inhaler) development services to advance molecules, drawing on 25 years of experience in particle engineering, formulation design, and encapsulation techniques. Our premier particle engineering technologies services, utilizing both jet milling and spray drying, are tailored to your molecule, target product profile and delivery device. Dedicated DPI […]
Merxin is a generic device supplier. We develop and supply inhalers “off the shelf and ready to use” to speed up finished product development. We make the world healthier, one breath at a time.
Proveris Laboratories evaluates the actual spray performance on formulation and device combination candidates. With this process the best device-formulation combination is selected by evaluating all key characteristics. The Proveris by Design™ experimental model thoroughly evaluates and documents the effect of each attribute, providing the most comprehensive insight into product performance.
Integrated services from preformulation, analytical testing and clinical supply to commercial manufacturing and packaging for all inhaled dosage forms including pMDI, DPI, nasal sprays, solution/suspension for inhalation.